SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-676980
Filing Date
2016-08-09
Accepted
2016-08-09 17:31:35
Documents
67
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d225552d10q.htm 10-Q 563295
2 EX-3.1 d225552dex31.htm EX-3.1 15969
3 EX-10.1 d225552dex101.htm EX-10.1 129051
4 EX-31 d225552dex311.htm EX-31 6386
5 EX-32 d225552dex32.htm EX-32 4312
  Complete submission text file 0001193125-16-676980.txt   3889878

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mnkd-20160630.xml EX-101.INS 508526
7 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20160630.xsd EX-101.SCH 49124
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnkd-20160630_cal.xml EX-101.CAL 64258
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnkd-20160630_def.xml EX-101.DEF 312986
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20160630_lab.xml EX-101.LAB 377799
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20160630_pre.xml EX-101.PRE 363217
Mailing Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355
Business Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355 6617755300
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50865 | Film No.: 161819366
SIC: 2834 Pharmaceutical Preparations